|
DHX40P1 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.702600E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.971600E-01 |
| Normal-vs-Stage2 |
4.217000E-01 |
| Normal-vs-Stage3 |
7.503700E-02 |
| Normal-vs-Stage4 |
8.097700E-02 |
| Stage1-vs-Stage2 |
4.653000E-01 |
| Stage1-vs-Stage3 |
1.175970E-03 |
| Stage1-vs-Stage4 |
1.724040E-03 |
| Stage2-vs-Stage3 |
1.372400E-01 |
| Stage2-vs-Stage4 |
1.549590E-01 |
| Stage3-vs-Stage4 |
7.880800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.953620E-01 |
| Normal-vs-AfricanAmerican |
3.678400E-01 |
| Normal-vs-Asian |
8.214200E-01 |
| Caucasian-vs-AfricanAmerican |
3.199000E-01 |
| Caucasian-vs-Asian |
1.024350E-01 |
| AfricanAmerican-vs-Asian |
2.201000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.269600E-01 |
| Normal-vs-Female |
4.524200E-01 |
| Male-vs-Female |
2.984200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.748800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.378040E-01 |
| Normal-vs-Age(61-80Yrs) |
1.326570E-01 |
| Normal-vs-Age(81-100Yrs) |
1.990580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.141930E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.111920E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.218000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.297400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.587400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.195400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.72289999999365E-05 |
| Classical-VS-Follicular |
8.237800E-01 |
| Classical-VS-Other |
7.601400E-01 |
| Classical-VS-Normal |
4.520600E-01 |
| Tall-VS-Follicular |
1.257580E-01 |
| Tall-VS-Other |
2.621000E-01 |
| Tall-VS-Normal |
4.742100E-02 |
| Follicular-VS-Other |
9.251400E-01 |
| Follicular-VS-Normal |
4.209800E-01 |
| Other-VS-Normal |
4.147600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.376000E-01 |
| Normal-vs-N1 |
9.532600E-01 |
| N0-vs-N1 |
3.803200E-01 |
|
|
